Sphingomyelin and sphingomyelin synthase (SMS) in the malignant transformation of glioma cells and in 2-hydroxyoleic acid therapy. [electronic resource]
Producer: 20120413Description: 19569-74 p. digitalISSN:- 1091-6490
- Apoptosis -- drug effects
- Bridged-Ring Compounds -- pharmacology
- Cell Cycle Checkpoints -- drug effects
- Cell Differentiation -- drug effects
- Cell Line, Tumor
- Cell Membrane -- drug effects
- Cell Survival -- drug effects
- Cell Transformation, Neoplastic
- Cells
- Gene Expression Regulation, Enzymologic
- Glioma -- genetics
- Humans
- Immunoblotting
- Jurkat Cells
- Membrane Microdomains -- drug effects
- Membrane Proteins -- antagonists & inhibitors
- Nerve Tissue Proteins -- antagonists & inhibitors
- Norbornanes
- Oleic Acids -- pharmacology
- Phosphodiesterase Inhibitors -- pharmacology
- Reverse Transcriptase Polymerase Chain Reaction
- Sphingomyelins -- metabolism
- Thiocarbamates
- Thiones -- pharmacology
- Transferases (Other Substituted Phosphate Groups) -- antagonists & inhibitors
- fas Receptor -- metabolism
- ras Proteins -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.